NCT06087016Completed
Urinary Markers by SpectrosCopy: Diagnostic Aid in oncologY - Application to Urological Cancers
Urinary Markers by SpectrosCopy: Diagnostic Aid in oncologY - Application to Urological Cancer
Source: ClinicalTrials.gov · Last updated 12 Jun 2026
Brief summary (registry, in English)
This study aims to evaluate the performance of vibrational spectroscopy (Infrared and Raman spectroscopy techniques) in bladder cancer diagnosis using urine samples.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 899 (actual)
- First submitted
- 11 Oct 2023
- Start date
- 6 Mar 2023
- Primary completion date
- 24 May 2024
- Lead sponsor
- CHU de Reims
- Diseases
- Bladder cancer
- NCT number
- NCT06087016
What you commit to
- Study type: Observational
- Participants enrolled: 899
- From 6 Mar 2023 to the primary completion date, 24 May 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- with a bladder fistula
Other
- Refused to participate in the study or unable to give consent
- without a native bladder
Who the study is looking for
- Must be over 18 years of age
- Able to give consent and understand the purpose the study
- Agree to participate in the study and having signed the non-objection document
- Admitted to a urology consultation for cystoscopy
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Damien JOLLY Coordinator of this site? Confirm its status | Reims | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.